LawPlayer
My bookmarks
Source

Commission Implementing Regulation (EU) 2016/305 of 3 March 2016 amending Regulation (EU) No 37/2010 as regards the substance ‘gentamicin’ (Text with EEA relevance)

Commission Implementing Regulation (EU) 2016/305 of 3 March 2016 amending Regulation (EU) No 37/2010 as regards the substance ‘gentamicin’ (Text with EEA relevance)

Implementing Regulation (EU) 2016/305 · Regulation · 3 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

The Annex to Regulation (EU) No 37/2010 is amended as set out in the Annex to this Regulation.

Article 2

Open ↗

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Supplementary provisions

ANNEXSupplementary provisions

Open ↗

ANNEX In Table 1 of the Annex to Regulation (EU) No 37/2010, the entry for the substance ‘gentamicin’ is replaced by the following: Pharmacologically active Substance Marker residue Animal Species MRLs Target Tissues Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009) Therapeutic Classification ‘Gentamicin Sum of gentamicin C1, gentamicin C1a, gentamicin C2 and gentamicin C2a All mammalian food producing species and fin fish 50 μg/kg 50 μg/kg 200 μg/kg 750 μg/kg 100 μg/kg Muscle Fat Liver Kidney Milk For fin fish the muscle MRL relates to “muscle and skin in natural proportions” For porcine species the fat relates to “skin and fat in natural proportions” Anti-infectious agents/Antibiotics’

Other acts of the same type
Commission Implementing Regulation (EU) 2024/2777 of 31 October 2024 concerning the non-renewal of approval of the active substance tritosulfuron, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011Commission Implementing Regulation (EU) 2024/2781 of 31 October 2024 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 8-hydroxyquinoline, aminopyralid, azoxystrobin, Candida oleophila strain O, chlorantraniliprole, fluroxypyr, imazalil, kresoxim-methyl, metobromuron, oxyfluorfen, Paecilomyces fumosoroseus strain FE 9901, tefluthrin and terbuthylazineCommission Implementing Regulation (EU) 2024/2794 of 31 October 2024 amending Implementing Regulation (EU) 2021/1378 as regards the recognition of certain control bodies in accordance with Article 46 of Regulation (EU) 2018/848 of the European Parliament and of the Council as competent to carry out controls and issue organic certificates in third countries for the purpose of imports of organic products into the UnionCommission Implementing Regulation (EU) 2024/2806 of 31 October 2024 concerning the non-renewal of the approval of the active substance metribuzin, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 and Commission Implementing Regulation (EU) 2015/408Commission Delegated Regulation (EU) 2025/65 of 31 October 2024 amending Delegated Regulation (EU) 2019/2123 as regards the conditions under which a separate Common Health Entry Document is submitted for consignments leaving a border control post for a control point where identity and physical checks are to be performedCommission Delegated Regulation (EU) 2025/296 of 31 October 2024 supplementing Regulation (EU) 2023/1114 of the European Parliament and of the Council with regard to regulatory technical standards specifying the procedure for the approval of a crypto-asset white paperCommission Delegated Regulation (EU) 2025/297 of 31 October 2024 supplementing Regulation (EU) 2023/1114 of the European Parliament and of the Council with regard to regulatory technical standards specifying the conditions for the establishment and functioning of consultative supervisory collegesCommission Delegated Regulation (EU) 2025/298 of 31 October 2024 supplementing Regulation (EU) 2023/1114 of the European Parliament and of the Council with regard to regulatory technical standards specifying the methodology to estimate the number and value of transactions associated to uses of asset-referenced tokens and of e-money tokens denominated in a currency that is not an official currency of a Member State as a means of exchangeCommission Delegated Regulation (EU) 2025/299 of 31 October 2024 supplementing Regulation (EU) 2023/1114 of the European Parliament and of the Council on markets in crypto-assets with regard to regulatory technical standards on continuity and regularity in the performance of crypto-asset servicesCommission Delegated Regulation (EU) 2025/303 of 31 October 2024 supplementing Regulation (EU) 2023/1114 of the European Parliament and of the Council with regard to regulatory technical standards specifying the information to be included by certain financial entities in the notification of their intention to provide crypto-asset servicesCommission Implementing Regulation (EU) 2025/304 of 31 October 2024 laying down implementing technical standards for the application of Regulation (EU) 2023/1114 of the European Parliament and of the Council with regard to standard forms, templates and procedures for the notification by certain financial entities of their intention to provide crypto-asset servicesCommission Delegated Regulation (EU) 2025/305 of 31 October 2024 supplementing Regulation (EU) 2023/1114 of the European Parliament and of the Council with regard to regulatory technical standards specifying the information to be included in an application for authorisation as a crypto-asset service provider

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next